In early January, @ashishkjha & I made case for delayed 2nd dose in @washingtonpost tinyurl.com/4gw77p08. In last few weeks, @mtosterholm, Stanley Plotkin, & now @ZekeEmanuel have come out in support of this strategy. To be clear, we appreciate the counterarguments,... (1/4)
https://twitter.com/CNNnewsroom/status/1362788551964979201
...particularly the messaging challenges (will some people forego 2nd dose?). But with the rapid spread of B117, the case for calling an audible for next 2 months & getting more people their 1st dose of Pfizer or Moderna has grown stronger. And this case is now bolstered (2/4)...
...by real-world data from Israel @thelancet (1st dose 85% effective in preventing symptomatic Covid) tinyurl.com/4w4476et & @NEJM (review of original @US_FDA data: 1st dose 92.6% effective) tinyurl.com/55hu7ws5.
Time's a wasting – increasingly clear that...(3/4)
Time's a wasting – increasingly clear that...(3/4)
...a big push to get as many people as possible their first doses in next 6 weeks will save lives overall.
In this week's @NEJM, I make this argument in a point/counterpoint nejm.org/doi/full/10.10…. And this was written before the new (& supportive) Lancet/NEJM studies.(4/4)
In this week's @NEJM, I make this argument in a point/counterpoint nejm.org/doi/full/10.10…. And this was written before the new (& supportive) Lancet/NEJM studies.(4/4)
• • •
Missing some Tweet in this thread? You can try to
force a refresh
